{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:31:33Z","timestamp":1775212293639,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.expneurol.2004.01.003","type":"journal-article","created":{"date-parts":[[2004,3,20]],"date-time":"2004-03-20T11:11:47Z","timestamp":1079781107000},"page":"137-149","source":"Crossref","is-referenced-by-count":65,"title":["Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice"],"prefix":"10.1016","volume":"187","author":[{"given":"Gabriele","family":"Schilling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena V.","family":"Savonenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Coonfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna L.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Vorovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Gale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Neslon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fromholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Borchelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2004.01.003_BIB1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?","volume":"31","author":"Beal","year":"1992","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.65020919.x","article-title":"3-Nitropropionic acid neurotoxicity is attenuated in copper\/zinc superoxide dismutase transgenic mice","volume":"65","author":"Beal","year":"1995","journal-title":"J. Neurochem"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/nbdi.1998.0168","article-title":"Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length","volume":"4","author":"Becher","year":"1998","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","article-title":"ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions","volume":"18","author":"Bruijn","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0092-8674(95)90273-2","article-title":"SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat","volume":"82","author":"Burright","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB6","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/hmg\/6.11.1951","article-title":"Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice","volume":"6","author":"Carlson","year":"1997","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0079-6123(08)63260-4","article-title":"Role of superoxide dismutase in ischemic brain injury: reduction of edema and infarction in transgenic mice following focal cerebral ischemia","volume":"96","author":"Chan","year":"1993","journal-title":"Prog. Brain Res"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB8","first-page":"271","article-title":"Neuroprotective role of CuZn-superoxide dismutase in ischemic brain damage","volume":"71","author":"Chan","year":"1996","journal-title":"Adv. Neurol"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB9","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1523\/JNEUROSCI.18-20-08292.1998","article-title":"Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion","volume":"18","author":"Chan","year":"1998","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB11","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.10374","article-title":"Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS","volume":"52","author":"Drachman","year":"2002","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB13","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1073\/pnas.84.22.8044","article-title":"Transgenic mice with increased Cu\/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome","volume":"84","author":"Epstein","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of Coenzyme Q10 and Remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1749-6632.1985.tb21489.x","article-title":"Molecular structure and expression of the gene locus on chromosome 21 encoding the Cu\/Zn superoxide dismutase and its relevance to Down syndrome","volume":"450","author":"Groner","year":"1985","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB16","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB17","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB18","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1073\/pnas.110138997","article-title":"Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy","volume":"97","author":"Heiser","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington's disease mice","volume":"51","author":"Hockly","year":"2002","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB21","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.275.15.11397","article-title":"The cyclooxygenase-2 inhibitor Celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2","volume":"275","author":"Hsu","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5715","article-title":"SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein","volume":"2","author":"Iadecola","year":"1999","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11910-002-0073-7","article-title":"Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development","volume":"2","author":"Jankowsky","year":"2002","journal-title":"Curr. Neurol. Neurosci. Rep"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/386493a0","article-title":"More hippocampal neurons in adult mice living in an enriched environment","volume":"386","author":"Kempermann","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0960-9822(07)00377-6","article-title":"Environmental stimulation of 129\/SvJ mice causes increased cell proliferation and neurogenesis in the adult dentate gyrus","volume":"8","author":"Kempermann","year":"1998","journal-title":"Curr. Biol"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/jhep.2002.36125","article-title":"Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells","volume":"36","author":"Kern","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB28","doi-asserted-by":"crossref","first-page":"11158","DOI":"10.1073\/pnas.88.24.11158","article-title":"Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase","volume":"88","author":"Kinouchi","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB29","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"Korth","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB30","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.10692","article-title":"Induction of apoptosis in rheumatoid synovial fibroblasts by Celecoxib, but not by other selective cyclooxygenase 2 inhibitors","volume":"46","author":"Kusunoki","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington's disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB32","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/hmg\/7.9.1355","article-title":"A cellular model that recapitulates major pathogenic steps of Huntington's disease","volume":"7","author":"Lunkes","year":"1998","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB34","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","article-title":"Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective efforts","volume":"95","author":"Matthews","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB35","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1161\/01.STR.28.9.1797","article-title":"Overexpression of CuZn-superoxide dismutase reduces hippocampal injury after global ischemia in transgenic mice","volume":"28","author":"Murakami","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3835(02)00003-4","article-title":"Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of Celecoxib and rofecoxib","volume":"180","author":"Patti","year":"2002","journal-title":"Cancer Lett"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB37","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/pro.5560031002","article-title":"Polar zippers: their role in human disease","volume":"3","author":"Perutz","year":"1994","journal-title":"Protein Sci"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB38","doi-asserted-by":"crossref","first-page":"41032","DOI":"10.1074\/jbc.M205809200","article-title":"Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization","volume":"277","author":"Poirier","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00005792-199709000-00001","article-title":"Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA)","volume":"76","author":"Ross","year":"1997","journal-title":"Medicine"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nm874","article-title":"A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects","volume":"9","author":"Samlowski","year":"2003","journal-title":"Nat. Med"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB42","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","article-title":"Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology","volume":"96","author":"Scherzinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic pathology in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(01)02326-6","article-title":"Coenzyme Q10 and Remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model","volume":"315","author":"Schilling","year":"2001","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/nbdi.2001.0385","article-title":"Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA","volume":"8","author":"Schilling","year":"2001","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/exnr.1998.7005","article-title":"Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein","volume":"156","author":"Sieradzan","year":"1999","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB47","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1006\/nbdi.2001.0438","article-title":"Inhibition of polyglutamine aggregation in R6\/2 HD brain slices-complex dose\u2013response profiles","volume":"8","author":"Smith","year":"2001","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01376517-200106000-00005","article-title":"Remotivation therapy and Huntington's disease","volume":"33","author":"Sullivan","year":"2001","journal-title":"J. Neurosci. Nurs"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","article-title":"A randomized, placebo-controlled trial of Coenzyme Q10 and Remacemide in Huntington's disease","volume":"57","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB50","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0968-0896(03)00070-1","article-title":"Manganese-based complexes of radical scavengers as neuroprotective agents","volume":"11","author":"Vajragupta","year":"2003","journal-title":"Bioorg. Med. Chem"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB51","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","article-title":"Delaying the onset of Huntington's in mice","volume":"404","author":"van Dellen","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB53","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/nbdi.2002.0498","article-title":"Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site","volume":"10","author":"Wang","year":"2002","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB55","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","article-title":"An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria","volume":"14","author":"Wong","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0014-5793(02)03535-4","article-title":"Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells","volume":"531","author":"Yamazaki","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.expneurol.2004.01.003_BIB57","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J. Neurosci"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448860400010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448860400010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T09:24:27Z","timestamp":1550136267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448860400010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S001448860400010X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.01.003","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}